Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMC 4205105)

Published in Circulation on June 15, 2009

Authors

Eileen Hsich1, Eiran Z Gorodeski, Randall C Starling, Eugene H Blackstone, Hemant Ishwaran, Michael S Lauer

Author Affiliations

1: Department of Cardiovascular Medicine, Cleveland Clinic and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Articles cited by this

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

Exercise capacity and mortality among men referred for exercise testing. N Engl J Med (2002) 14.30

Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA (1996) 7.45

The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA (2005) 6.32

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26

Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol (2007) 3.92

Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA (2003) 3.64

Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA (2000) 3.24

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant (2006) 2.86

Effects of gender on peak oxygen consumption and the timing of cardiac transplantation. J Am Coll Cardiol (2006) 2.18

Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation (1999) 1.88

Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation (2005) 1.88

Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol (2008) 1.79

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol (1989) 1.61

The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. J Heart Lung Transplant (2008) 1.51

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am Heart J (2000) 1.28

Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med (1998) 1.26

A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med (2004) 1.20

Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail (2001) 1.11

Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol (2005) 1.05

Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men. Am J Cardiol (2008) 0.96

Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%. Am J Cardiol (2008) 0.90

Long-term prognostic value of peak oxygen consumption in women versus men with heart failure and severely impaired left ventricular systolic function. Am J Cardiol (2007) 0.90

Quantitative measures of electrocardiographic left ventricular mass, conduction, and repolarization, and long-term survival after coronary artery bypass grafting. Circulation (2007) 0.82

Prognostic value of cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy in a non-beta-blocker therapy setting. Eur J Heart Fail (2008) 0.81

Exercise endpoints in patients with chronic heart failure. Int J Cardiol (2000) 0.80

Articles by these authors

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23

HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37

Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33

Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol (2009) 5.76

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2007) 5.40

Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med (2013) 5.10

The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03

Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95

Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77

Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation (2007) 4.66

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56

7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52

A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46

Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer (2010) 4.40

Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med (2010) 4.31

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation (2003) 4.25

Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant (2010) 4.00

Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A (2007) 3.92

Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med (2003) 3.61

Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50

Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47

Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37

Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35

Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA (2004) 3.34

Use of annulus washer after debridement: a new mitral valve replacement technique for patients with severe mitral annular calcification. J Thorac Cardiovasc Surg (2013) 3.31

The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25

Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol (2012) 3.17

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med (2002) 3.01

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91

Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology (2002) 2.87

Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA (2006) 2.82

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol (2007) 2.82

Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation (2005) 2.81

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78

Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76

Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol (2012) 2.75

Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA (2011) 2.73

Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A (2008) 2.64

Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg (2006) 2.62

Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm (2012) 2.60

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 2.58

Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56

Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation (2004) 2.54

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50

Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol (2008) 2.47

Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging (2009) 2.41

P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol (2011) 2.39

Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg (2004) 2.37

Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34

A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31

Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26

Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation (2005) 2.26

Are all readmissions bad readmissions? N Engl J Med (2010) 2.22

Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20

Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18

Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J (2007) 2.14

A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13

Editorial: An 'actual' problem: Another issue of apples and oranges. J Heart Valve Dis (2005) 2.11

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol (2011) 2.10

Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail (2014) 2.09

Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09

Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08

Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07

Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06

Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04

The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg (2004) 2.03

Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. J Thorac Cardiovasc Surg (2005) 2.03

Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99

Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg (2008) 1.99

Random forests for genomic data analysis. Genomics (2012) 1.98

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant (2010) 1.97

Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol (2008) 1.89

Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation (2005) 1.88

Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol (2008) 1.87

Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol (2009) 1.86

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation (2008) 1.85